Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,048.42 -23.21 (-0.46%) Dow
38,085.80 -375.12 (-0.98%) Nasdaq
15,611.76 -100.99 (-0.64%) Bitcoin USD
64,690.60 +826.50 (+1.29%) CMC Crypto 200
1,393.80 +11.23 (+0.81%)
Abcam plc (ABCZF)
| Previous close | 22.25 |
| Open | 22.25 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 22.25 - 22.25 |
| 52-week range | 5.00 - 23.80 |
| Volume | |
| Avg. volume | 0 |
| Market cap | 5.121B |
| Beta (5Y monthly) | 0.86 |
| PE ratio (TTM) | 2,225.00 |
| EPS (TTM) | 0.01 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 19 Mar 2020 |
| 1y target est | N/A |
ZacksDanaher (DHR) Acquires Abcam to Boost Life Sciences Segment
Danaher (DHR) acquires Abcam for $5.7 billion, thus adding to its Life Sciences portfolio. This move will facilitate the mapping of complex diseases and expedite the drug discovery process.
- Reuters
UPDATE 1-Danaher completes $5.7 billion acquisition of Abcam
Medical tools supplier Danaher said on Wednesday it has completed the $5.7 billion acquisition of Abcam, overcoming the initial opposition from the founder of the protein consumables maker. Danaher agreed to buy Abcam in September for $24 per share to expand its portfolio of products and services, but founder Jonathan Milner opposed it saying the offer undervalued the company. Milner, who owns a 6.14% stake, had said he would vote against the acquisition.
PR NewswireDanaher Completes Acquisition of Abcam
Danaher Corporation (NYSE:DHR) ("Danaher") announced today it has completed its acquisition of Abcam plc (NASDAQ:ABCM) ("Abcam").
